Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SofPulse
Los Angeles, California, United Statessofpulse.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
SofPulse devices have demonstrated reductions in post-surgical pain and swelling and decreased narcotic use in several published clinical studies (including double-blind, randomized, controlled pilot trials in breast surgery and other indications). The product is FDA-cleared for palliative treatment of pain and edema and was recently approved by the Taiwan FDA for post-operative use[2][3][6][8].
- Therapeutic areas
- DermatologyImmunologyNeurologyCardiovascular
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Therapeutic Medical Devices
02
Partnerships
EverMed Medical Enterprises (Taiwan distribution partner)
Beyond the preview
Go deeper on SofPulse.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SofPulse.